DAILY FINANCIAL WISDOM: "A year from now you will have wished you had truly started learning to trade today..."
Reward 1 - 2451 Reward 2 - 2459 Risk - 2272
So what's ailing Indian Pharma sector stocks? Those who really looked like on steroids are suddenly behaving like they have swallowed over dose of laxatives. Few environmental changes are to blame, 1. ) Rotation Yes folks, those who rode it from Rs. 100 a stock to 1500 are taking profit and putting that money to some other sector where they believe market it...
DAILY FINANCIAL WISDOM: Amateur traders focus on rewards. Professional traders focus on risk..
DAILY FINANCIAL WISDOM: "If you always do what you've always done, you will always get what you've always got...."
inverted head and shoulder in dr reddys lab, in the rise of nifty, pharma stocks are left behind will drreddy lab cover the back log. likely to go for targets of 2900 to 3000 in around one month.
near long term bottom...risk reward ratio makes it a better choice for positional trader
Looks like the stock is headed higher. The volume is slowly picking up..looking for target of 3100 and more.
NSE:DRREDDY Classic ABCD pattern has formed in daily chart of DRREDDY. The C point has formed at 0.62 and CD has formed at 1.56 of "BC". Bullish Entry can be made at 2990 for a target of 3250. SL 2960. www.tradingview.com
NSE:DRREDDY Bullish Classic ABCD pattern has formed in daily chart of DRREDDY. The C point has formed at 0.62 and CD has formed at 1.56 of BC. Entry can be made at 2990 for a target of 3200. SL 2960.
Fundamentally a STRONG company and it had recent news for its upmove Dr Reddy's Laboratories has expanded strategic collaboration with Amgen, one of the world's leading independent biotechnology companies, to market and distribute three of Amgen's medicines in India in the therapy areas of oncology and osteoporosis. Under the terms of the collaboration, the...
There was a gap down observed on daily chart which is been not filled up for a long time. Now the price action breaks out from a rectangular consolidation and shall reach out to 3280 levels in order to fill up that GAP. Target: 3280 Stoploss: 3070
ENTRY 2950-300 RANGE SL 2850 TGT 1 : 3300 TGT 2 : 3600 TGT 3 : 4400
India's one of the biggest drug maker is going to release quarterly results soon and its stock is already feeling the jitters. Analysts and news papers will annotate the appropriate headline but someone who is aware about the technicals will of course be taking profit at this levels. A solid up trend from the beginning of 2009 is still in effect but it is...